Total Payments
$132,912
2024 Payments
$18,460
Companies
11
Transactions
116
Medicare Patients
208
Medicare Billing
$26,263
Payment Breakdown by Category
Consulting$78,585 (59.1%)
Research$44,783 (33.7%)
Travel$5,069 (3.8%)
Other$3,000 (2.3%)
Food & Beverage$1,475 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $78,585 | 37 | 59.1% |
| Unspecified | $44,783 | 17 | 33.7% |
| Travel and Lodging | $5,069 | 31 | 3.8% |
| Honoraria | $3,000 | 1 | 2.3% |
| Food and Beverage | $1,475 | 30 | 1.1% |
Payments by Type
General
$88,130
99 transactions
Research
$44,783
17 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB SA | $52,194 | 49 | $0 (2024) |
| Medtronic USA, Inc. | $20,445 | 6 | $0 (2020) |
| Medtronic, Inc. | $17,400 | 8 | $0 (2023) |
| Neurelis, Inc. | $14,981 | 8 | $0 (2024) |
| UCB, Inc. | $9,817 | 27 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $7,457 | 8 | $0 (2019) |
| SK Life Science, Inc. | $3,060 | 2 | $0 (2023) |
| NEUROPACE, INC. | $2,640 | 4 | $0 (2017) |
| Acorda Therapeutics, Inc | $2,400 | 2 | $0 (2017) |
| UCB GmBH | $2,400 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,460 | 15 | Neurelis, Inc. ($9,431) |
| 2023 | $11,579 | 5 | UCB SA ($7,150) |
| 2022 | $10,461 | 5 | Medtronic, Inc. ($6,960) |
| 2021 | $11,145 | 6 | Medtronic, Inc. ($6,960) |
| 2020 | $19,820 | 6 | Medtronic USA, Inc. ($16,820) |
| 2019 | $11,648 | 10 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($7,082) |
| 2018 | $31,926 | 32 | UCB SA ($31,348) |
| 2017 | $17,873 | 37 | UCB SA ($7,505) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Neurelis, Inc. | VALTOCO (Drug) | Consulting Fee | Cash or cash equivalent | $2,965.00 | General |
| Category: EPILEPSY | ||||||
| 12/06/2024 | Neurelis, Inc. | VALTOCO (Drug) | Consulting Fee | Cash or cash equivalent | $4,407.00 | General |
| Category: EPILEPSY | ||||||
| 12/06/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $103.25 | General |
| Category: EPILEPSY | ||||||
| 11/22/2024 | UCB SA | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 11/20/2024 | Neurelis, Inc. | VALTOCO (Drug) | Consulting Fee | Cash or cash equivalent | $1,956.00 | General |
| Category: EPILEPSY | ||||||
| 10/11/2024 | UCB SA | — | Consulting Fee | Cash or cash equivalent | $4,750.00 | General |
| 06/11/2024 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 05/16/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $426.20 | General |
| 05/16/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $128.40 | General |
| 05/16/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $67.12 | General |
| 05/16/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $49.82 | General |
| 05/16/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $46.43 | General |
| 05/16/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $39.79 | General |
| 05/16/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $12.86 | General |
| 05/16/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $8.39 | General |
| 11/30/2023 | UCB SA | — | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| 11/10/2023 | UCB SA | — | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| 09/21/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $59.98 | General |
| 06/21/2023 | Neurelis, Inc. | VALTOCO (Drug) | Consulting Fee | Cash or cash equivalent | $889.50 | General |
| Category: EPILEPSY | ||||||
| 01/12/2023 | Medtronic, Inc. | VISUALASE (Device) | — | Cash or cash equivalent | $3,480.00 | Research |
| Study: SLATE • Category: MRI-guided laser ablation | ||||||
| 08/03/2022 | Medtronic, Inc. | VISUALASE (Device) | — | Cash or cash equivalent | $1,740.00 | Research |
| Study: SLATE • Category: MRI-guided laser ablation | ||||||
| 04/27/2022 | Neurelis, Inc. | VALTOCO (Drug) | Consulting Fee | Cash or cash equivalent | $3,480.00 | General |
| Category: EPILEPSY | ||||||
| 04/21/2022 | Medtronic, Inc. | VISUALASE (Device) | — | Cash or cash equivalent | $4,350.00 | Research |
| Study: SLATE • Category: MRI-guided laser ablation | ||||||
| 04/13/2022 | Medtronic, Inc. | VISUALASE (Device) | — | Cash or cash equivalent | $870.00 | Research |
| Study: SLATE • Category: MRI-guided laser ablation | ||||||
| 04/06/2022 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: EPILEPSY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SLATE | Medtronic, Inc. | $17,400 | 8 |
| Phase 2 OPC-214870 Epilepsy study | Otsuka Pharmaceutical Development & Commercialization, Inc. | $6,188 | 2 |
| SLATE | Medtronic USA, Inc. | $5,220 | 2 |
| SAD IN EPILEPSY | Otsuka Pharmaceutical Development & Commercialization, Inc. | $750.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 42 | 63 | $75,207 | $6,094 |
| 2022 | 2 | 46 | 73 | $26,129 | $5,444 |
| 2021 | 3 | 51 | 74 | $8,035 | $5,776 |
| 2020 | 3 | 69 | 88 | $17,418 | $8,949 |
Total Patients
208
Total Services
298
Medicare Billing
$26,263
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 13 | 28 | $62,328 | $4,277 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 24 | $7,104 | $1,327 | 18.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 11 | 11 | $5,775 | $489.17 | 8.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 62 | $18,352 | $3,961 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $7,777 | $1,483 | 19.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 52 | $4,749 | $3,455 | 72.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $1,860 | $1,373 | 73.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 11 | $1,427 | $947.97 | 66.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 28 | 28 | $8,455 | $3,520 | 41.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 36 | $4,578 | $3,051 | 66.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 23 | 24 | $4,385 | $2,379 | 54.2% |
About Dr. Joseph Sirven, M.D
Dr. Joseph Sirven, M.D is a Neurology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770565640.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Sirven, M.D has received a total of $132,912 in payments from pharmaceutical and medical device companies, with $18,460 received in 2024. These payments were reported across 116 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($78,585).
As a Medicare-enrolled provider, Sirven has provided services to 208 Medicare beneficiaries, totaling 298 services with total Medicare billing of $26,263. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Jacksonville, FL
- Active Since 11/16/2005
- Last Updated 08/28/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1770565640
Products in Payments
- VISUALASE (Device) $22,620
- VALTOCO (Drug) $14,981
- Vimpat (Drug) $2,841
- RNS System (Device) $2,640
- AMPYRA (Drug) $1,200
- Briviact (Drug) $600.00
- VNS Therapy (Device) $117.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Jacksonville
Dr. Zhigao Huang, Md, MD
Neurology — Payments: $776,793
Neurology $776,793
Steven Toenjes, M.d, M.D
Neurology — Payments: $625,564
Neurology $625,564
Dr. Michael Pulley, Md, MD
Neurology — Payments: $141,011
Neurology $141,011
Dr. Erin Doty, Md, MD
Neurology — Payments: $71,947
Neurology $71,947
Bjorn Oskarsson, Md, MD
Neurology — Payments: $37,588
Neurology $37,588
Dr. Anthony Ritaccio, M.d, M.D
Neurology — Payments: $34,326
Neurology $34,326